Featured Research

from universities, journals, and other organizations

Baylor Team Discovers Reason For Heart Transplant Failure

Date:
May 18, 2001
Source:
Baylor College Of Medicine
Summary:
A common virus that infects the heart is a major reason for heart transplant failure in children, researchers at Baylor College of Medicine have discovered.

HOUSTON (May 17, 2001) -- A common virus that infects the heart is a major reason for heart transplant failure in children, researchers at Baylor College of Medicine have discovered.

"This finding should lead to a change in diagnostic testing and treatment," said Dr. Jeffrey A. Towbin, a professor of pediatric cardiology at Baylor. "It could also improve long-term survival."

The discovery, reported in the May 17 issue of the New England Journal of Medicine, shows why many children suffer heart transplant failure months and even years after surgery, including cardiac rejection and the development of transplant coronary artery disease. The study indicates that frequent biopsies are the best method to identify the virus.

The research team, led by Towbin and Dr. Neil E. Bowles, an assistant professor of pediatric cardiology at Baylor, has been studying for the past decade the reasons for heart transplant failure in children. "It's been the bane of all transplant doctors -- the development of coronary artery disease in transplant patients leads to either sudden death or the need for retransplantation," said Towbin, also associate chief of pediatric cardiology at Texas Children's Hospital and director of the Heart Failure and Transplant Service and Cardiac Research. "Nobody has understood why this happens, but now we know there's a viral connection."

The team studied 553 biopsies from 149 transplant recipients, ages newborn to 18 years old, over a five-year period. The biopsies were evaluated for common viral infections by using a polymerase chain reaction, or PCR, test. All of the biopsies were sent from Loma Linda University Children's Hospital in California.

Results showed that 85 percent of the patients who at some point after transplant tested PCR-positive suffered an adverse event within three months of that result.

"The infection isn't there at transplant, it wasn't there along the way and suddenly it's there," Towbin said. "It's likely to be due to an upper respiratory illness."

In the majority of cases, the infection was late onset, appearing more than two years after transplant, Bowles said. The infections or evidence of rejection did not show up on non-invasive tests.

The findings indicate that the current therapy for transplant rejection should be changed, Towbin said. Now, when the heart shows signs of rejection, indicated by inflammation within the heart, the therapy is anti-inflammatory medications, such as steroids and increased immunosuppresent drugs. After the therapy reduces the inflammation, the patient is sent home with a clean bill of health, he said.

"But, nothing has been done about the virus. It's still sitting there as a low-level illness that over time creates the problem," Towbin said.

Towbin and Bowles said the discovery suggests that all heart transplant patients should be biopsied routinely with PCR evaluation performed each time. They believe these results could lead to new therapies and preventative measures, such as an anti-viral vaccine for use prior to transplant.

Collaborators included Dr. Girish S. Shirali, Medical University of South Carolina, Charleston; Dr. Jiyuan Ni, Baylor College of Medicine; Dr. Richard E. Chinnock and Joyce K. Johnston, Loma Linda University Children's Hospital; and Dr. Geoffrey L. Rosenthal, University of Washington.


Story Source:

The above story is based on materials provided by Baylor College Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Baylor College Of Medicine. "Baylor Team Discovers Reason For Heart Transplant Failure." ScienceDaily. ScienceDaily, 18 May 2001. <www.sciencedaily.com/releases/2001/05/010518083338.htm>.
Baylor College Of Medicine. (2001, May 18). Baylor Team Discovers Reason For Heart Transplant Failure. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2001/05/010518083338.htm
Baylor College Of Medicine. "Baylor Team Discovers Reason For Heart Transplant Failure." ScienceDaily. www.sciencedaily.com/releases/2001/05/010518083338.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins